The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era

Cancer Epidemiology

Volumn 34, Issue 3, 2010, Pages 257-261

  Serraino, Diego ^a   De Paoli, Angela ^a   Zucchetto, Antonella ^a   Pennazza, Simona ^b   Bruzzone, Silvia ^b   Spina, Michele ^a   De Paoli, Paolo ^a   Rezza, Giovanni ^c   Dal Maso, Luigino ^a   Suligoi, Barbara ^c  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b ITALIAN NATIONAL INSTITUTE OF STATISTICS   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AIDS; Kaposi sarcoma; Mortality; Non Hodgkin lymphoma

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; DEATH CERTIFICATE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; ITALY; KAPOSI SARCOMA; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARDIZED MORTALITY RATIO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SARCOMA, KAPOSI;

EID: 77952238765     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.03.011     Document Type: Article

References (27)

1. Franceschi S., Dal Maso L., Rickenbach M., Polesel J., Hirschel B., Cavassini M., et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 99 (2008) 800-804
2. Polesel J., Clifford G.M., Rickenbach M., Dal Maso L., Battegay M., Bouchardy C., et al. Non-Hodgkin lymphoma incidence in the Swiss HIV cohort study before an after highly active antiretroviral therapy. AIDS 22 (2008) 301-306
3. Mocroft A., Kirk O., Clumeck N., Gargalianos-Kakolyris P., Trocha H., Chentsova N., et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003. Cancer 100 (2004) 2644-2654
4. Kirk O., Pedersen C., Cozzi-Lepri A., Antunes F., Miller V., Gatell J.M., et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98 (2001) 3406-3412
5. Serraino D., Piselli P., Busnach G., Burra P., Citterio F., Arbustini E., et al. Risk of cancer following immune suppression in organ transplant recipients and HIV-positive individuals in southern Europe. Eur J Cancer 43 (2007) 2117-2123
6. Dal Maso L., Polesel J., Serraino D., Lise M., Piselli P., Falcini F., et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 100 (2009) 840-847
7. Biggar R.J., Engels E.A., Ly S., Kahn A., Schymura M.J., Sackoff J., et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 39 (2005) 293-299
8. Vaccher E., Spina M., Talamini R., Zanetti M., Di Gennaro G., Nasti G., et al. Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma out come in the era of highly active antiretroviral therapy. Clin Infect Dis 37 (2003) 1556-1564
9. Mounier N., Spina M., Gabarre J., Raphael M., Rizzardini G., Golfier J.B., et al. AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 107 (2006) 3832-3840
10. Du Pont C., Vasseur E., Beauchet A., Aegerter P., Berthé H., de Truchis P., et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine. AIDS 14 (2000) 987-993
11. Selik R.M., Byer R.H., and Dworkin M.S. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29 (2002) 378-387
12. Hooshyar D., Hanson D.L., Wolfe M., Selik R.M., Buskin S.E., and McNaghten A.D. Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS 21 (2002) 2093-2100
13. Serraino D., Zucchetto A., Suligoi B., Bruzzone S., Camoni L., Boros S., et al. Survival after AIDS diagnosis in Italy, 1999-2006: a population-based study. J Acquir Immune Defic Syndr 51 (2009) 99-102
14. Ancelle Park R.A. Expanded European AIDS case definition. Lancet 341 (1993) 441
15. Conti S., Masocco M., Pezzotti P., Toccaceli V., Vichi M., Boros S., et al. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 25 (2000) 451-458
16. Pezzotti P., Napoli P.A., Acciai S., Boros S., Urciuoli R., Lazzeri V., et al. Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. AIDS 13 (1999) 249-255
17. Conti S., Farchi G., Galletti A., Masocco M., Napoli P.A., Pezzotti P., et al. La notifica della mortalità per AIDS in Italia (1992): qualità della certificazione e sottonotifica. Giornale italiano dell'AIDS 8 (1997) 12-16
18. Breslow N.E., and Day N.E. Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sc. Pub. No. 82 (1987), International agency for research on cancer, Lyon
19. Spina M., Carbone A., Vaccher E., Gloghini A., Talamini R., Cinelli R., et al. Outcome in patients with non-Hodgkin lymphoma and with or without human immunodeficiency virus infection. Clin Infect Dis 38 (2004) 142-144
20. Spina M., Jaeger U., Sparano J.A., Talamini R., Simonelli C., Michieli M., et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide (R-CDE) in HIV-associated non-Hodgkin's lymphoma: pooled results from three phase II trials. Blood 105 (2005) 1891-1897
21. Re A., Michieli M., Casari S., Allione B., Cattaneo C., Rupolo M., et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood 114 (2009) 1306-1313
22. Chadborn T.R., Delpech V.C., Sabin C.A., Sinka K., and Evans B.G. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 20 (2006) 2371-2379
23. Valdez H., Chowdhry T.K., Asaad R., Woolley I.J., Davis T., Davidson R., et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 32 (2001) 1487-1493
24. French A.L., Gawel S.H., Hershow R., Benning L., Hessol N.A., Levine A.M., et al. Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr 51 (2009) 399-406
25. Louie J.K., Hsu L.C., Osmond D.H., Katz M.H., and Schwarcz S.K. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis 186 (2002) 1023-1027
26. Pacheco A.G., Tuboi S.H., May S.B., Moreira L.F., Ramadas L., Nunes E.P., et al. Temporal changes in cause of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 51 (2009) 624-630
27. Selik R.M., and Rabkin C.S. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90 (1998) 1300-1302